Navigation Links
InterMune Announces Posting of Briefing Documents for FDA Advisory Committee Meeting on Pirfenidone
Date:3/5/2010

d the likelihood of regulatory success. All forward-looking statements and other information included in this press release are based on information available to InterMune as of the date hereof, and InterMune assumes no obligation to update any such forward-looking statements or information. InterMune's actual results could differ materially from those described in InterMune's forward-looking statements. Pirfenidone failed to achieve statistical significance on the primary endpoint in one of its two pivotal clinical trials and there can be no assurance that the regulatory authorities in either the United States or Europe will grant regulatory approval based upon these data, in combination with the other efficacy analyses and safety results the company has submitted in support of its NDA and MAA filings.  Factors that could cause or contribute to such differences include, but are not limited to, those discussed in detail in the risk factors attached as Exhibit 99.3 to InterMune's Form 8-K filed with the SEC on January 20, 2010, and other periodic reports filed with the SEC, including the following: (i) risks related to the long, expensive and uncertain clinical development and regulatory process, including having no unexpected safety, toxicology, clinical or other issues or delays in anticipated timing of the regulatory approval process; (ii) risks related to failure to achieve the clinical trial results required to commercialize our product candidates; and (iii) risks related to timely patient enrollment and retention in clinical trials. The risks and other factors discussed above should be considered only in connection with the fully discussed risks and other factors discussed in detail in the Form 8-K and InterMune's other periodic reports filed with the SEC. InterMune undertakes no duty or obligation to update any forward-looking statements contained in this relea
'/>"/>
SOURCE InterMune, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. InterMune Reports Fourth Quarter and Full Year 2009 Financial Results and Business Highlights
2. InterMune to Participate in Pulmonary-Allergy Drugs Advisory Committee Meeting on March 9, 2010
3. InterMune to Present at Deutsche Bank Biotech Confab
4. InterMune Reports Third Quarter 2009 Financial Results and Business Highlights
5. InterMune Announces Submission of NDA for Pirfenidone for the Treatment of Patients with IPF
6. InterMune to Present at JMP Securities Conference
7. InterMune Reports Presentation of Triple Combination Study of ITMN-191 at European Association for the Study of the Liver (EASL)
8. InterMune to Announce Results of Phase 3 CAPACITY Program of Pirfenidone in IPF Tomorrow, February 3
9. InterMune to Conduct Conference Call and Webcast to Discuss Results of Triple Combination Study of ITMN-191
10. InterMune to Report Top-Line Results of Triple Combination Study of ITMN-191 in January 2009
11. Roche, InterMune and Pharmasset Announce Initiation of INFORM-1, the First Dual-Combination Clinical Trial with Oral Antivirals in Hepatitis C
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)...  Hill-Rom Holdings, Inc. (NYSE: HRC ) ... the Morgan Stanley Global Healthcare Conference on September 8, ... invited to listen to the live discussion via the ... directly at http://cc.talkpoint.com/morg007/090814a_ac/?entity=26_7CLOGQP .  A recorded replay of ... of the live event and accessible at the links ...
(Date:8/27/2014)... , Aug. 27, 2014 North American lighting ... prestigious R&D 100 Award for the new OSRAM ITOS ® ... LED-based white light module for microscopy, endoscopy and surgical head ... with significantly higher efficacy and lamp life. "We,re ... one of the most innovative new technologies of the past ...
(Date:8/27/2014)... , Aug. 27, 2014 Amgen (NASDAQ: ... Drug Administration (FDA) has granted priority review designation for ... Ivabradine is an oral drug that inhibits the ... sinoatrial node, the body,s cardiac pacemaker. 1 Ivabradine ... on myocardial contractility or ventricular repolarization. 1 Heart ...
Breaking Medicine Technology:OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 2OSRAM ITOS PHASER 3000 Laser and LED Light Module Recognized With Prestigious R&D 100 Award 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 2FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 3FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 4FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 5FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 6FDA Grants Amgen Priority Review Designation For Ivabradine For The Treatment Of Chronic Heart Failure 7
... 2011 Omthera Pharmaceuticals, Inc., a privately-held emerging ... President and Chief Executive Officer, will present at ... the Westin St. Francis Hotel in San Francisco, ... PT. About Omthera Pharmaceuticals, Inc.Founded ...
... Medical Technologies, Inc. today announced that Allina Hospitals ... company,s integrated electronic health record (EHR) practice management ... across Minnesota and western Wisconsin. ... ability to interface tightly with Allina,s Epic-based electronic ...
Cached Medicine Technology:Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 2Greenway's PrimeSUITE Endorsed by Allina Hospitals & Clinics 3
(Date:8/28/2014)... MarijuanaDoctors.com is enthralled to announce the addition ... Livermore, California. As always, MarijuanaDoctors.com prides itself on affiliating ... in accordance with that, we are excited to introduce ... , Initially finding his calling for healing and interest ... shaped by his mother’s severe arthritis to finally become ...
(Date:8/28/2014)... Texas (PRWEB) August 28, 2014 The need ... growth over the past few years. The new location - ... offer higher quality and larger office space than TLC had ... , “We are pleased about our new location because ... “While our suite will be double in size compared to ...
(Date:8/27/2014)... Villanova, PA (PRWEB) August 28, 2014 ... (published by iUniverse) takes readers on the thrilling adventures ... The book, published in 2012, is gearing up for ... 2014. , Split into two novellas , “Prescription: ... orthopedic surgeon who finds himself dodging assassination attempts and ...
(Date:8/27/2014)... Recently, BambooIndustry.com, an innovative company that provides many kinds of ... panels are now offered on its website. In addition, ... All people that place an order for its newly released ... percent off. , The company’s senior spokesman was excited ... our new and old customers can buy cheap bamboo panels ...
(Date:8/27/2014)... National Resident Matching Program International ... Medical Education in Europe (AMEE) Conference being held at ... – September 3, 2014. As an exhibitor, NRMPI ... community, share the benefits of its matching services, and ... in countries throughout the world. , “Exhibiting ...
Breaking Medicine News(10 mins):Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 2Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 3Health News:Army Colonel Dr. James Patel Joins the Medical Marijuana Industry 4Health News:William H. Simon Launches New Marketing Campaign for Book 2Health News:BambooIndustry.com: Cheap Bamboo Panels for Clients Worldwide Offered Online 2Health News:National Resident Matching Program International (NRMPI) to Exhibit at the 2014 AMEE Conference 2
... 23 James. G. Schwade, M.D. announces the newly enhanced CyberKnife ... ( www.cyberknifemiami.com ). , The CyberKnife treatment for cancer ... cells with no invasive surgical incision. The length of the ... usually completed in 1- 5 treatments. , As the ...
... 20 percent get infected within one year of starting to ... News) -- As many as one in four U.S. teenage ... soon after their first sexual encounter, a new government report ... reminds us that we can,t ignore this," said study author ...
... is leading an initiative that could result in a paradigm ... Morehouse University School of Medicine and University of ... care physicians across Georgia to serve as "medical homes" for ... sends them to the hospital and seeking better prevention and ...
... , ... Instacare Corp. (OTC Bulletin Board: ISCR) announced today that its ... e-health technologies have been successfully engineered to seamlessly function on ... hand-held interactive medical software to the Apple iPhone, the Palm ...
... , NEW ORLEANS, Nov. 23 Thanksgiving weekend marks the 36th annual ... the sportsmanship and pride of two schools but it is so much ... in attendance. , For the crew of the new U.S. Coast Guard ... before they work to test and launch a brand new ship to ...
... ... and Automate Billing, Claims, Enrollment and Eligibility, , ... (PRWEB) November 23, 2009 -- BridgeGate ... the launch of new products within its healthcare integration suite, designed to help ...
Cached Medicine News:Health News:One in Four Teen Girls Have STDs 2Health News:One in Four Teen Girls Have STDs 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 2Health News:Initiative could result in paradigm shift in the care of sickle cell patients 3Health News:Initiative could result in paradigm shift in the care of sickle cell patients 4Health News:Initiative could result in paradigm shift in the care of sickle cell patients 5Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 2Health News:ISCR Becomes Instant Player in the Obamacare EMR/Cost Savings Sweepstakes 3Health News:Nothing Is Like Being There 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 2Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 3Health News:BridgeGate Launches New Healthcare Integration and Interoperability Products 4
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: